Connection

GUILLERMINA LOZANO to Antineoplastic Agents

This is a "connection" page, showing publications GUILLERMINA LOZANO has written about Antineoplastic Agents.
Connection Strength

0.173
  1. Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy. Clin Cancer Res. 2013 Jan 01; 19(1):34-41.
    View in: PubMed
    Score: 0.087
  2. Restoring p53 in cancer: the promises and the challenges. J Mol Cell Biol. 2019 07 19; 11(7):615-619.
    View in: PubMed
    Score: 0.034
  3. p53 and MDM2: antagonists or partners in crime? Cancer Cell. 2009 Mar 03; 15(3):161-2.
    View in: PubMed
    Score: 0.017
  4. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 2006 Jun; 13(6):927-34.
    View in: PubMed
    Score: 0.014
  5. Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer. Elife. 2024 Aug 30; 13.
    View in: PubMed
    Score: 0.012
  6. Differential roles of p21(Waf1) and p27(Kip1) in modulating chemosensitivity and their possible application in drug discovery studies. Mol Pharmacol. 2001 Nov; 60(5):900-6.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.